| Total (n= 214) | Hematologic (n= 115, 54%) | Solid (n= 99, 46%) | P value |
---|---|---|---|---|
Age (years) | 60 (51-68) | 56 (44-67) | 62 (56-69) | 0.002 |
Gender (male) | 144 (67) | 77 (67) | 67 (68) | 0.911 |
Co-morbidities | 111 (52) | 59 (51) | 52 (53) | 0.859 |
   Cardiovascular | 40 | 19 | 21 |  |
   Respiratory | 25 | 11 | 14 |  |
   Hepatic | 10 | 4 | 6 |  |
   Renal | 4 | 3 | 1 |  |
   Diabetes | 2 | 2 | 0 |  |
   Othersa | 15 | 12 | 3 |  |
ECOG performance status (3 or more) | 61 (28) | 35 (30) | 26 (26) | 0.500 |
Type of malignancy | Â | Â | Â | Â |
   Solid | 98 (46) |  |  |  |
   Hematologic | 116 (54) |  |  |  |
Status of malignancy | Â | Â | Â | Â |
   Relapsed/refractory | 64 (30) | 34 (30) | 30 (30) | 0.906 |
   Extensive disease or major organ involvement | 151 (71) | 66 (58) | 85 (86) | <0.001 |
Stem cell transplantation | 28 (13) | 28 (24) | 0 | Â |
   Allogenic | 11 | 11 |  |  |
   Autologous | 17 | 17 |  |  |
Duration of malignancy, months | 8.2 (2.9-19.4) | 7.4 (2.6-18.2) | 8.5 (3.1-24.0) | 0.154 |
Clinical status on ICU admission | Â | Â | Â | Â |
   Antibacterial agents | 210 (98) | 115 (100) | 95 (96) | 0.044 |
   Recent chemotherapy prior to ICU admission within 4 weeks | 89 (42) | 45 (39) | 44 (44) | 0.487 |
   Need for mechanical ventilationb | 109 (51) | 43 (37) | 66 (67) | <0.001 |
   Need for vasopressor support | 52 (24) | 28 (24) | 24 (24) | 0.986 |
   Need for renal replacement therapy | 19 (9) | 16 (14) | 3 (3) | 0.005 |
Laboratory findings | Â | Â | Â | Â |
   WBC,/μL | 6,305 (2,250-12,378) | 3,030 (730-7,280) | 10,220 (5,330-15,670) | <0.001 |
ANC,/μL | 3,970 (995-8,545) | 1,700 (240-4,570) | 7,520 (3380-12,680) | <0.001 |
Neutropenia (ANC <500/μL) | 40 (18) | 32 (28) | 8 (8) | <0.001 |
   Platelet, 103/μL | 112.5 (29.0-234.8) | 35.0 (16.0-117.0) | 187.0 (116.0-271.0) | <0.001 |
   CRP, mg/dL | 14.8 (7.4-22.3) | 12.1 (5.5-19.8) | 16.2 (10.4-24.0) | 0.003 |
   Procalcitonin, ng/mL | 0.65 (0.19-2.85) | 0.72 (0.19-3.70) | 0.56 (0.17-2.29) | 0.443 |
   pH | 7.444 (7.375-7.474) | 7.452 (7.400-7.483) | 7.433 (7.362-7.465) | 0.017 |
   NT-proBNP, pg/mL | 1392 (273-4796) | 2,108 (445-8,780) | 940 (239 - 3424) | 0.035 |
   PF ratio | 145 (105-214) | 160 (109-234) | 134 (101 - 181) | 0.075 |
Severity of illness | Â | Â | Â | Â |
   SAPS 3 (points) | 61 (50-75) | 65 (52-78) | 58 (48-66) | 0.002 |
   SOFA score (points) | 6 (3-8) | 6 (4-9) | 5 (3-8) | 0.013 |
Length of stay in ICU (days) | 6 (3-13) | 5 (2-10) | 7 (3-16) | 0.012 |
Length of stay in hospital (days) | 26 (15-44) | 31 (17-59) | 21 (12-34) | 0.002 |
ICU mortality | 64 (30) | 33 (29) | 31 (31) | 0.765 |
In-hospital mortality | 105 (49) | 55 (48) | 50 (51) | 0.784 |
90-day mortality | 138 (65) | 68 (59) | 70 (71) | 0.087 |